NYSE:ALBAlbemarle Stock Price, Forecast & News

Albemarle's stock was trading at $70.07 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ALB shares have increased by 20.5% and is now trading at $84.44.
View which stocks have been most impacted by Coronavirus.

25 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 5 sell ratings, 12 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Albemarle.

Albemarle is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Albemarle.

Albemarle Co. (NYSE:ALB) posted its quarterly earnings results on Wednesday, August, 5th. The specialty chemicals company reported $0.86 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.72 by $0.14. Albemarle had a return on equity of 13.33% and a net margin of 12.99%.
View Albemarle's earnings history.

Albemarle declared a quarterly dividend on Tuesday, July 14th. Shareholders of record on Friday, September 18th will be paid a dividend of $0.385 per share on Thursday, October 1st. This represents a $1.54 dividend on an annualized basis and a yield of 1.82%. The ex-dividend date of this dividend is Thursday, September 17th.
View Albemarle's dividend history.

Albemarle updated its third quarter 2020 After-Hours earnings guidance on Wednesday, August, 5th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $700-775 million, compared to the consensus revenue estimate of $717.55 million.

25 brokers have issued 1-year price targets for Albemarle's shares. Their forecasts range from $39.50 to $116.00. On average, they anticipate Albemarle's stock price to reach $75.50 in the next twelve months. This suggests that the stock has a possible downside of 10.6%.
View analysts' price targets for Albemarle.

News coverage about ALB stock has been trending negative recently, according to InfoTrie. The research group scores the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Albemarle earned a coverage optimism score of -2.0 on InfoTrie's scale. They also assigned media headlines about the specialty chemicals company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the immediate future.
View the latest news about Albemarle.

Some companies that are related to Albemarle include Sherwin-Williams (SHW), Ecolab (ECL), International Flavors & Fragrances (IFF), Celanese (CE), RPM International (RPM), Ashland Global (ASH), NewMarket (NEU), Quaker Chemical (KWR), Balchem (BCPC), W. R. Grace & Co (GRA), Stepan (SCL), HB Fuller (FUL), PolyOne (POL), Sensient Technologies (SXT) and Innospec (IOSP).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Albemarle investors own include Intact Financial (IFC), Constellation Software (CSU), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Vermilion Energy (VET), Wheaton Precious Metals (WPM), Rogers Communications (RCI), Open Text (OTEX) and Alibaba Group (BABA).

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Albemarle's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include ProShare Advisors LLC (1.23%), KAMES CAPITAL plc (1.00%), US Bancorp DE (0.88%), New York State Common Retirement Fund (0.47%), Marathon Asset Management LLP (0.47%) and Sumitomo Mitsui Trust Holdings Inc. (0.46%). Company insiders that own Albemarle stock include Deeanne J Marlow, Eric Norris, Karen G Narwold, Luther C Iv Kissam and Scott Tozier.
View institutional ownership trends for Albemarle.

ALB stock was sold by a variety of institutional investors in the last quarter, including Eastern Bank, Robecosam AG, Edmond DE Rothschild Holding S.A., Zurcher Kantonalbank Zurich Cantonalbank, Capital Management Corp VA, Victory Capital Management Inc., Oregon Public Employees Retirement Fund, and Candriam Luxembourg S.C.A.. Company insiders that have sold Albemarle company stock in the last year include Karen G Narwold, Luther C Iv Kissam, and Scott Tozier.
View insider buying and selling activity for Albemarle.

ALB stock was acquired by a variety of institutional investors in the last quarter, including US Bancorp DE, Marathon Asset Management LLP, Zweig DiMenna Associates LLC, Hardman Johnston Global Advisors LLC, Great Lakes Advisors LLC, Moody Lynn & Lieberson LLC, KAMES CAPITAL plc, and SG Americas Securities LLC. Company insiders that have bought Albemarle stock in the last two years include Deeanne J Marlow, and Eric Norris.
View insider buying and selling activity for Albemarle.

Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ALB stock can currently be purchased for approximately $84.44.

Albemarle has a market capitalization of $8.98 billion and generates $3.59 billion in revenue each year. The specialty chemicals company earns $533.23 million in net income (profit) each year or $6.04 on an earnings per share basis. Albemarle employs 6,000 workers across the globe.

The official website for Albemarle is www.albemarle.com.

Albemarle's mailing address is 4250 CONGRESS STREET SUITE 900, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700 or via email at [email protected]